Reports total Q1 2026 revenue of $3.4 million, representing year-over-year growth of 122% - - Received IDE approval from FDA to initiate the CGUARDIANS III clinical trial of its SwitchGuard ...
Powell Industries, Inc. (NASDAQ: POWL) ("Powell" or the "Company"), a leading supplier of custom-engineered solutions for the management, control and distribution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results